| Karl H Hanson Jr, M D | |
|
9703 Overbrook Rd, Leawood, KS 66206-2309 | |
| (913) 381-0548 | |
| Not Available |
| Full Name | Karl H Hanson Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 9703 Overbrook Rd, Leawood, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073806410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 04-12313 (Kansas) | Primary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2004001947 (Missouri) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Karl H Hanson Jr, M D 9703 Overbrook Rd, Leawood, KS 66206-2309 Ph: (913) 381-0548 | Karl H Hanson Jr, M D 9703 Overbrook Rd, Leawood, KS 66206-2309 Ph: (913) 381-0548 |
News Archive
Among people recently infected with HIV, immediate antiretroviral therapy (ART) appears preferable to deferring treatment, according to a new study published in The Journal of Infectious Diseases and now available online.
News outlets examine what's behind the activity during recent town-hall meetings as activists voice concerns about the GOP spending plan, which was advanced by Rep. Paul Ryan, R-Wis. Experts wonder, though, whether the mounting criticism is organic or rooted in Washington political theatrics.
Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" were associated with greater vaccine efficacy. The results were published today in the online edition of the journal Nature.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Despite tried and true methods to quit smoking, young adults do not take advantage of these proven smoking cessation treatments that can double their chances of quitting, University of Illinois at Chicago public health researchers report.
› Verified 9 days ago
Dr. Robert Mark Ross, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 12823 Sagamore Rd, Leawood, KS 66209 Phone: 913-449-1721 Fax: 913-498-2358 | |
Dr. Shelley Lynn Alexander, D.O. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10557 Mission Rd, Leawood, KS 66206 Phone: 913-213-6900 Fax: 913-213-6729 | |
Yelena Pinzur, D.O. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 8800 State Line Rd, Leawood, KS 66206 Phone: 913-383-9099 Fax: 816-383-3103 | |
Stany A Dsilva, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8800 State Line Rd, Leawood, KS 66206 Phone: 913-383-9099 Fax: 913-383-3103 | |
Marcus A. Neubauer, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 11805 Brookwood Ave, Leawood, KS 66211 Phone: 913-451-5620 | |
Laura Badjalimbe, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10977 Granada Ln Ste 105, Leawood, KS 66211 Phone: 816-822-0050 Fax: 816-447-3960 |